Competitor Analysis: Therapeutic Proteins – Biosimilars, Biobetters & Biosuperiors
The new Competitive Intelligence Report Therapeutic Proteins – Biosimilars, Biobetters & Biosuperiors of May 2013 provides a competitor analysis in the product portfolios and development pipelines of ten major classes of therapeutic proteins and their biosimilar and biobetter/biosuperior versions in regulated and less regulated markets:
- Erythropoietin (EPO) & Erythropoiesis Stimulating Agents (ESA)
- G-CSF & GM-CSF
- Thrombopoietin & Thrombopoiesis Stimulating Agents
- Coagulation Factors
- Human Growth Hormone (hGH)
- FSH, hCG and LH: Therapeutic Proteins for Assisted Reproductive Technology (ART)
- Thrombolytics & Fibrinolytics
- Enzyme Replacement Therapies
To Read the Complete Report with TOC Visit: http://www.marketresearchreports.biz/analysis/167445
Territories covered are the major pharmaceutical markets North America, Europe and Japan, as well as South Korea, India, China and other countries in Latin America, Africa and Australasia.
With more than US$ 50 bln in sales, therapeutic proteins represent a major category of pharmaceutical products with established therapeutic value and high economic attractiveness. As more and more of the branded products are running out of patent protection and regulatory agencies are providing better guidance, development of biosimilar versions as well as of improved next generation versions are a highly attractive goal for pharmaceutical and biotechnology as well as technology focused companies.
This report includes a compilation of current active projects in research and development of biosimilar and novel biobetter/biosuperior therapeutic proteins as well as non-protein based competitor products and an overview of approved products in regulated and less regulated markets. Competitor projects are listed in a tabular format providing Information on:
To Buy The Copy of This Report Visit: http://www.marketresearchreports.biz/analysis-details/competitor-analysis-therapeutic-proteins-biosimilars-biobetters-and-biosuperiors
- Drug Codes,
- Target / Mechanism of Action,
- Class of Compound,
- Product Category,
- R&D Stage and
- additional comments with a hyperlink leading to the source of information.
Global WLAN Equipment Market 2012-2016: http://www.marketresearchreports.biz/analysis/160202
TechNavio's analysts forecast the Global WLAN Equipment market to grow at a CAGR of 17.81 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing adoption of smartphones and tablets. The Global WLAN Equipment market has also been witnessing the increasing enterprise mobility. However, the network security issues could pose a challenge to the growth of this market.
TechNavio's report, the Global WLAN Equipment Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global WLAN Equipment market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
MarketResearchReports.Biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are especially designed to save time and money of our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
90 Sate Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-997-4948